Subscribe to RSS
DOI: 10.1055/s-0036-1579546
Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study
Publication History
11 August 2015
06 December 2015
Publication Date:
10 March 2016 (online)
Abstract
Introduction Obstructive sleep apnea (OSA) is characterized by partial or complete recurrent upper airway obstruction during sleep. OSA brings many adverse consequences, such as hypertension, obesity, diabetes mellitus, cardiac and encephalic alterations, behavioral, among others, resulting in a significant source of public health care by generating a high financial and social impact. The importance of this assessment proves to be useful, because the incidence of patients with comorbidities associated with AOS has been increasing consistently and presents significant influence in natural disease history.
Objective The objective of this study is to assess major comorbidities associated with obstructive sleep apnea (OSA) and prevalence in a group of patients diagnosed clinically and polysomnographically with OSA.
Methods This is a retrospective study of 100 charts from patients previously diagnosed with OSA in our service between October 2010 and January 2013.
Results We evaluated 100 patients with OSA (84 men and 16 women) with a mean age of 50.05 years (range 19–75 years). The prevalence of comorbidities were hypertension (39%), obesity (34%), depression (19%), gastroesophageal reflux disease (GERD) (18%), diabetes mellitus (15%), hypercholesterolemia (10%), asthma (4%), and no comorbidities (33%). Comorbidities occurred in 56.2% patients diagnosed with mild OSA, 67.6% with moderate OSA, and 70% of patients with severe OSA.
Conclusion According to the current literature data and the values obtained in our paper, we can correlate through expressive values obesity with OSA and their apnea hypopnea index (AHI) values. However, despite significant prevalence of OSA with other comorbidities, our study could not render expressive significance values able to justify their correlations.
-
References
- 1 Cintra FD. Obstrutive sleep apnea as a risk factor for cardiovascular disease. . Rev Bras Hipertensão 2013; 20 (1) 7-9
- 2 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328 (17) 1230-1235
- 3 Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010; 11 (5) 441-446
- 4 Kapsimalis F, Kryger M. Sleep breathing disorders in the U.S. female population. J Womens Health (Larchmt) 2009; 18 (8) 1211-1219
- 5 Jennum P, Sjøl A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992; 1 (4) 240-244
- 6 Marrone O, Lo Bue A, Salvaggio A, Dardanoni G, Insalaco G. Comorbidities and survival in obstructive sleep apnoea beyond the age of 50. Eur J Clin Invest 2013; 43 (1) 27-33
- 7 Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008; 5 (2) 136-143
- 8 Aurora RN, Punjabi NM. Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med 2013; 1 (4) 329-338
- 9 Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82 (5) 1313-1316
- 10 Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83 (3) 847-850
- 11 Moreira RO, Santos RD, Martinez L , et al. [Lipid profile of patients with increased risk for cardiovascular events in daily clinical practice]. Arq Bras Endocrinol Metabol 2006; 50 (3) 481-489
- 12 Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990; 120 (3) 672-676
- 13 Kannel WB. Lessons from curbing the coronary artery disease epidemic for confronting the impending epidemic of heart failure. Med Clin North Am 2004; 88 (5) 1129-1133 , ix
- 14 Avezum A, Piegas LS, Pereira JC. Risk factors associated with acute myocardial infarction in the São Paulo metropolitan region: a developed region in a developing country. Arq Bras Cardiol 2005; 84 (3) 206-213
- 15 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464) 1046-1053
- 16 Cintra FD, Poyares D, Guilleminault C, Carvalho AC, Tufik S, de Paola AA. [Cardiovascular comorbidities and obstructive sleep apnea]. Arq Bras Cardiol 2006; 86 (6) 399-407
- 17 Shepherd KL, James AL, Musk AW, Hunter ML, Hillman DR, Eastwood PR. Gastro-oesophageal reflux symptoms are related to the presence and severity of obstructive sleep apnoea. J Sleep Res 2011; 20 (1 Pt 2) 241-249
- 18 Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc 2008; 5 (2) 185-192
- 19 Shah N, Roux F. The relationship of obesity and obstructive sleep apnea. Clin Chest Med 2009; 30 (3) 455-465 , vii vii
- 20 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328 (17) 1230-1235
- 21 Nieto FJ, Young TB, Lind BK , et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14) 1829-1836
- 22 Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284 (23) 3015-3021
- 23 Newman AB, Nieto FJ, Guidry U , et al; Sleep Heart Health Study Research Group. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154 (1) 50-59
- 24 Foster GD, Sanders MH, Millman R , et al; Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009; 32 (6) 1017-1019
- 25 Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg?. Diabetes Care 2008; 31 (Suppl. 02) S303-S309
- 26 Vgontzas AN. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?. Arch Physiol Biochem 2008; 114 (4) 211-223
- 27 Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90 (1) 47-112
- 28 Schwartz AR, Patil SP, Squier S, Schneider H, Kirkness JP, Smith PL. Obesity and upper airway control during sleep. J Appl Physiol (1985) 2010; 108 (2) 430-435
- 29 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção de Saúde. Vigitel Brasil 2012: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico – Brasília: Ministério da Saúde, 2013
- 30 Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991; 99 (4) 861-866
- 31 Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998; 157 (1) 111-115
- 32 Logan AG, Perlikowski SM, Mente A , et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19 (12) 2271-2277
- 33 Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320 (7233) 479-482
- 34 Nieto FJ, Young TB, Lind BK , et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14) 1829-1836
- 35 O'Connor GT, Caffo B, Newman AB , et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009; 179 (12) 1159-1164
- 36 Sateia MJ. Update on sleep and psychiatric disorders. Chest 2009; 135 (5) 1370-1379
- 37 Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28 (11) 1405-1411
- 38 McCall WV, Harding D, O'Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med 2006; 2 (4) 424-426
- 39 Saunamäki T, Jehkonen M. Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand 2007; 116 (5) 277-288
- 40 Dominici M, Gomes MdaM. Obstructive sleep apnea (OSA) and depressive symptoms. Arq Neuropsiquiatr 2009; 67 (1) 35-39
- 41 Macey PM, Woo MA, Kumar R, Cross RL, Harper RM. Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PLoS ONE 2010; 5 (4) e10211
- 42 Suganuma N, Shigedo Y, Adachi H , et al. Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep. Psychiatry Clin Neurosci 2001; 55 (3) 255-256
- 43 Gislason T, Janson C, Vermeire P , et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 2002; 121 (1) 158-163
- 44 Green BT, Broughton WA, O'Connor JB. Marked improvement in nocturnal gastroesophageal reflux in a large cohort of patients with obstructive sleep apnea treated with continuous positive airway pressure. Arch Intern Med 2003; 163 (1) 41-45
- 45 Oztürk O, Oztürk L, Ozdogan A, Oktem F, Pelin Z. Variables affecting the occurrence of gastroesophageal reflux in obstructive sleep apnea patients. Eur Arch Otorhinolaryngol 2004; 261 (4) 229-232
- 46 Berg S, Hoffstein V, Gislason T. Acidification of distal esophagus and sleep-related breathing disturbances. Chest 2004; 125 (6) 2101-2106
- 47 Konermann M, Radü HJ, Teschler H, Rawert B, Heimbucher J, Sanner BM. Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis. Am J Otolaryngol 2002; 23 (1) 20-26
- 48 Tasali E, Leproult R, Spiegel K. Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Prog Cardiovasc Dis 2009; 51 (5) 381-391
- 49 Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ ; International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81 (1) 2-12
- 50 Elmasry A, Lindberg E, Berne C , et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2) 153-161
- 51 Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007; 13 (4) 355-362
- 52 Laaban JP, Daenen S, Léger D , et al. Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 2009; 35 (5) 372-377
- 53 Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008; 5 (2) 207-217
- 54 Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34 (1) 243-260
- 55 McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007; 175 (2) 190-195
- 56 Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25 (9) 735-741
- 57 Roche F, Sforza E, Pichot V , et al; PROOF Study Group. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 2009; 10 (8) 882-886
- 58 Tan KC, Chow WS, Lam JC , et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006; 184 (2) 377-382
- 59 Salles C, Terse-Ramos R, Souza-Machado A, Cruz ÁA. Obstructive sleep apnea and asthma. J Bras Pneumol 2013; 39 (5) 604-612
- 60 Prasad B, Nyenhuis SM, Weaver TE. Obstructive sleep apnea and asthma: associations and treatment implications. Sleep Med Rev 2014; 18 (2) 165-171
- 61 Puthalapattu S, Ioachimescu OC. Asthma and obstructive sleep apnea: clinical and pathogenic interactions. J Investig Med 2014; 62 (4) 665-675
- 62 Braido F, Baiardini I, Lacedonia D , et al; Italian Society of Respiratory Medicine (SIMeR). Sleep apnea risk in subjects with asthma with or without comorbid rhinitis. Respir Care 2014; 59 (12) 1851-1856
- 63 Teodorescu M, Barnet JH, Hagen EW, Palta M, Young TB, Peppard PE. Association between asthma and risk of developing obstructive sleep apnea. JAMA 2015; 313 (2) 156-164
- 64 Reid MB, Lännergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 2002; 166 (4) 479-484
- 65 Guilleminault C, Quera-Salva MA, Powell N , et al. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J 1988; 1 (10) 902-907
- 66 National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120 (5, Suppl) S94-S138